Clinical Trial Update: Magenta Elevate™ EFS in High-Risk PCI Patients [NA]

View source ↗

Summary

Clinical trial update notes that the Magenta Elevate EFS study in high-risk percutaneous coronary intervention has completed; results are not provided in the up…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Magenta Elevate

Snippet

Sponsor: Magenta Medical Ltd. | Conditions: High-risk Percutaneous Coronary Intervention | NA | Status: COMPLETED